Nitro-dur and Gaviscon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitro-dur (nitroglycerin) and Gaviscon (aluminum hydroxide; magnesium trisilicate). Common drug interactions include psychomotor retardation among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Nitro-dur and Gaviscon. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Nitro-dur?

Nitro-dur has active ingredients of nitroglycerin. eHealthMe is studying from 2,414 Nitro-dur users. Check the latest studies of Nitro-dur.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

On Aug, 02, 2026

16 people who take Nitro-dur and Gaviscon together, and have interactions are studied.

Nitro-dur and Gaviscon drug interactions.

What are the common drug interactions of Nitro-Dur and Gaviscon, by gender? *:

female:

Psychomotor retardation (motor mental retardation)
Dyspnoea (difficult or laboured respiration)
Hypertension (high blood pressure)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Mitral valve incompetence (inefficient heart valve)
Sepsis (a severe blood infection that can lead to organ failure and death)
Stomach discomfort (pain in abdomen)
Hyponatraemic syndrome (serum sodium concentration below 135 mmol/l)
Drop attacks (sudden spontaneous falls while standing or walking)
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)

male:

Anxiety

What are the common drug interactions of Nitro-Dur and Gaviscon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anxiety

50-59:

n/a

60+:

Psychomotor retardation (motor mental retardation)
Hyponatraemic syndrome (serum sodium concentration below 135 mmol/l)
Hypertension (high blood pressure)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Mitral valve incompetence (inefficient heart valve)
Sepsis (a severe blood infection that can lead to organ failure and death)
Stomach discomfort (pain in abdomen)
Drop attacks (sudden spontaneous falls while standing or walking)
Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
Pulmonary oedema (fluid accumulation in the lungs)

What are the existing conditions these people have? *

Insomnia (sleeplessness): 13 people, 81.25%
High Blood Pressure: 13 people, 81.25%
Depression: 11 people, 68.75%
Stable Angina (a constant chest pain): 2 people, 12.50%
Pain: 2 people, 12.50%
Osteoporosis (bones weak and more likely to break): 2 people, 12.50%
Multiple Myeloma (cancer of the plasma cells): 2 people, 12.50%
Macular Degeneration (painless eye condition that leads to the gradual loss of central vision): 2 people, 12.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 12.50%
Gastric Ulcer (stomach ulcer): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Nitro-dur and Gaviscon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously